Pomalidomide decreases fibrosis in the lesion areas of the pancreas of KC mice. Pomalidomide decreases fibrosis in the lesion areas of the pancreas of.

Slides:



Advertisements
Similar presentations
Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model  Ana Hidalgo-Sastre, Roxanne L.
Advertisements

SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models. SCC244 significantly inhibited c-Met–driven tumor growth in cancer CDX models.
18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition. 18F-FDG uptake is a noninvasive biomarker of combined MEK–mTORC1 inhibition.
Sunitinib plus rMVA–CEA–TRICOM vaccine decreased tumor burden and increased intratumoral infiltration of T lymphocytes in the MC38-CEA colon carcinoma.
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
CD1dhiCD5+ B cells are expanded in pancreatic neoplasia and are functionally important for sustaining growth of KrasG12D-PDEC in vivo. CD1dhiCD5+ B cells.
Insulin content of isolated pancreas and islet morphology.
Volume 21, Issue 6, Pages (June 2012)
Atg7 deficiency has distinct consequences for tumor establishment and maintenance in BrafV600E-driven lung tumors and is associated with the emergence.
Covering the Cover Gastroenterology
Deficiency of Cdkn2a leads to aberrant activation of RhoA in vivo.
Cytotoxic therapy induces CSF1-dependent macrophage recruitment.
Fig. 5 Local gel scaffold for T cell memory response.
Depletion of Drosha in the endothelium in mice results in embryonic developmental vascular abnormalities similar to HHT. Depletion of Drosha in the endothelium.
Molecular Therapy - Methods & Clinical Development
KRAS-induced chemoattractants mediate attraction of macrophages.
Elysse C. Filipe et al. BTS 2018;3:38-53
Volume 22, Issue 3, Pages (September 2012)
Pten deficiency induces strong stromal reaction with immune cell infiltration and promotes the development of invasive and metastatic pancreatic tumors.
2aG4 directly induces monocytic MDSCs to differentiate into dendritic cells and macrophages by binding to phosphatidylserine on their cell surface. 2aG4.
Effect of antiangiogenic TKIs and rMVA–CEA–TRICOM vaccine on tumor compactness, tight junctions, and intratumoral pressure in the MC38-CEA model. Effect.
Obesity aggravates tumor desmoplasia.
B cells infiltrate mouse and human pancreatic neoplasia and promote growth of KrasG12D-PDEC in vivo. B cells infiltrate mouse and human pancreatic neoplasia.
The MEK inhibitor CI‐1040 reverses thickening, fibrosis, and angiogenesis in the parietal peritoneum of Cav1−/− mice upon exposure to PD fluidWT or Cav1−/−
Pharmacologic inhibition of eIF5A hypusination sensitizes KRas-driven tumor cells to MEK and KRas inhibition. Pharmacologic inhibition of eIF5A hypusination.
Fig. 6. Nontaxane chemotherapies induce TMEM-dependent prometastatic changes in the breast cancer microenvironment. Nontaxane chemotherapies induce TMEM-dependent.
SW fraction induces S phase arrest and apoptosis.
Metformin and rapamycin decreased tumor weights in obese prediabetic mice. Metformin and rapamycin decreased tumor weights in obese prediabetic mice. A:
Higher levels of PEDF-impaired skin structure and function.
GLP-1 and gastrin combination therapy increases pancreatic insulin content (A) and β-cell mass (B) in NOD mice. GLP-1 and gastrin combination therapy increases.
Chop deletion preserves β-cell function in P58IPK−/− mice.
CPI-444 efficacy requires CD8+ T cells and is associated with increased CD73 expression. CPI-444 efficacy requires CD8+ T cells and is associated with.
Glucose-stimulated insulin secretion, plasma glucagon levels, and pancreatic hormone contents. Glucose-stimulated insulin secretion, plasma glucagon levels,
Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal tumors. Effect of mitomycin C and bortezomib on the growth of LS174T intraperitoneal.
Autophagy restrains pancreatic inflammation and expression of pTBK1, CCL5, and PD-L1 in vivo. Autophagy restrains pancreatic inflammation and expression.
Effects of AG on the colon histology score in the acute DSS colitis model. Effects of AG on the colon histology score in the acute DSS colitis model. Ten.
mTORC1 is required for malignant transformation in the Eμ-Myc model.
Accelerated metastasis spread in tumor-bearing mice treated with paclitaxel and anakinra. Accelerated metastasis spread in tumor-bearing mice treated with.
Rapamycin decreases PD-L1 expression in lung tumors in vivo.
Dose-dependent effect of IP6 feeding on molecules associated with tumor sustenance and glucose transportation in dorsolateral prostate of TRAMP mice. Dose-dependent.
MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting Sox2. MiR-200c suppresses tumor growth and metastasis of CRC in vivo by targeting.
PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. PVHA increased anti-PD-L1–mediated growth inhibition in 4T1/HAS3 tumors. A, 4T1/HAS3.
HCCs with overexpression of biliary/progenitor marker genes.
FKBP1b counters the age-related decrease in hippocampal MAP2 protein expression. FKBP1b counters the age-related decrease in hippocampal MAP2 protein expression.
T-cell activation and induction of apoptosis in epithelial cells of oral lesions induced by 4-NQO. T-cell activation and induction of apoptosis in epithelial.
Presence of TNF and ECM degradation are consequences of abundance of macrophages in regions of ADM. A, pancreata of p48Cre;LSL-KrasG12D treated with PBS.
M-CSFR inhibition decreases tumor-associated macrophages in mesothelioma and improves the DC therapy induced CD8+ T-cell phenotype. M-CSFR inhibition decreases.
Prostate tumor progression in TgAPT121 mice is accelerated and diversified by Pten heterozygosity. Prostate tumor progression in TgAPT121 mice is accelerated.
Ketogenic diets combined with fractionated radiation treatment results in decreased immunoreactive PCNA in tumor tissue. Ketogenic diets combined with.
The responses of H292 and A549 lung cancer xenografts to hypofractionated radiation were enhanced by the ketogenic diet. The responses of H292 and A549.
Circulating leukocytes are undetectable in blood vessels of solid tumors in RIP1-Tag2 mice even after IL-15/IL-15Rα complex treatment. Circulating leukocytes.
Chronic Treg reduction results in dermal fibrosis.
Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant tumors. Dasatinib overcomes the growth and metastatic spread of vemurafenib-resistant.
Effect of CDV on human SF7796 xenografts in vivo.
Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8 and Stat3+/+:HPV8 mice. Expression of PCNA, K10, and K5 in skin lesions from Stat3+/−:HPV8.
The effect of a DIO regimen ± EPA+DHA supplementation on tumor growth.
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
PI3Kγ promotes macrophage PDGF-BB expression to control PDAC fibrosis.
NIX loss delays cancer progression in KRAS-driven models of PDAC
PDL192 and inhibit the growth of xenograft tumors.
Volume 14, Issue 10, Pages (March 2016)
AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. AXL-on tumors are heterogeneous for AXL expression and EdU incorporation. A,
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Recruitment of CD8+, CD4+, and Foxp3+ cells into oral lesions in response to anti–PD-1 treatment. Recruitment of CD8+, CD4+, and Foxp3+ cells into oral.
BH3-targeted inhibitors drive specific resistance in human cell lines, which can be overcome with alternating or combining inhibitors. BH3-targeted inhibitors.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
The tumorous pancreas has an abundant microbiome and its ablation is protective against pancreatic disease progression. The tumorous pancreas has an abundant.
SCLC initiated from pulmonary neuroendocrine cells metastasizes without upregulating NFIB. A and B, Mouse models of SCLC. Rb1flox/flox;Trp53flox/flox;p130flox/flox;R26mTmG.
PD and efficacy of AZD4785 in a KRAS wild-type lung cancer PDX model
Fig. 6 tlr2 is necessary for SASP activation in vivo.
Presentation transcript:

Pomalidomide decreases fibrosis in the lesion areas of the pancreas of KC mice. Pomalidomide decreases fibrosis in the lesion areas of the pancreas of KC mice. A–D, Control mice or KC mice at an age of 8 weeks were treated with pomalidomide every day for 4 weeks (treatment scheme depicted in Supplementary Fig. S1). At an age of 12 weeks, pancreata were harvested and abnormal areas analyzed. A, Hematoxylin and eosin (H&E) staining of representative areas. Scale bar, 50 μm. B, The bar graph shows a quantification of the abnormal areas in control- or pomalidomide-treated KC mice (n = 4 per treatment group). *, statistical significance (P < 0.05) as compared with control. The pie graphs show grading of pancreatic lesions and relative presence of ADM, ADM-PanIN transition areas, and PanIN1. C and D, Trichrome staining or IHC staining for SMA of lesion areas in KC mice after control or pomalidomide treatment. Representative areas are shown. Scale bar, 100 μm in C and 50 μm in D. E, Quantification of SMA content of abnormal pancreatic areas. IHC-stained samples (n = 3) from each treatment group were analyzed. The white bars show the SMA content at treatment start as a reference (n = 3 samples). *, statistical significance (P < 0.05). Ligia I. Bastea et al. Cancer Res 2019;79:1535-1548 ©2019 by American Association for Cancer Research